233 related articles for article (PubMed ID: 12169390)
1. Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines.
Colella R; Goodwyn E; Gopal P
Cancer Lett; 2002 Nov; 185(2):163-72. PubMed ID: 12169390
[TBL] [Abstract][Full Text] [Related]
2. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
Colella R; Jackson T; Goodwyn E
Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
[TBL] [Abstract][Full Text] [Related]
3. Matrigel influences morphology and cathepsin B distribution of prostate cancer PC3 cells.
Gopal P; Rehman RU; Chadha KS; Qiu M; Colella R
Oncol Rep; 2006 Aug; 16(2):313-20. PubMed ID: 16820909
[TBL] [Abstract][Full Text] [Related]
4. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
Colella R; Casey SF
Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
[TBL] [Abstract][Full Text] [Related]
5. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.
Friedrich B; Jung K; Lein M; Türk I; Rudolph B; Hampel G; Schnorr D; Loening SA
Eur J Cancer; 1999 Jan; 35(1):138-44. PubMed ID: 10211102
[TBL] [Abstract][Full Text] [Related]
6. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.
Premzl A; Puizdar V; Zavasnik-Bergant V; Kopitar-Jerala N; Lah TT; Katunuma N; Sloane BF; Turk V; Kos J
Biol Chem; 2001 May; 382(5):853-7. PubMed ID: 11517941
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64.
Navab R; Mort JS; Brodt P
Clin Exp Metastasis; 1997 Mar; 15(2):121-9. PubMed ID: 9062388
[TBL] [Abstract][Full Text] [Related]
8. Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C.
Coulibaly S; Schwihla H; Abrahamson M; Albini A; Cerni C; Clark JL; Ng KM; Katunuma N; Schlappack O; Glössl J; Mach L
Int J Cancer; 1999 Nov; 83(4):526-31. PubMed ID: 10508490
[TBL] [Abstract][Full Text] [Related]
9. A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells.
Boike G; Lah T; Sloane BF; Rozhin J; Honn K; Guirguis R; Stracke ML; Liotta LA; Schiffmann E
Melanoma Res; 1992; 1(5-6):333-40. PubMed ID: 1422189
[TBL] [Abstract][Full Text] [Related]
10. Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion.
Cuvier C; Jang A; Hill RP
Clin Exp Metastasis; 1997 Jan; 15(1):19-25. PubMed ID: 9009102
[TBL] [Abstract][Full Text] [Related]
11. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation.
Afonso S; Romagnano L; Babiarz B
Development; 1997 Sep; 124(17):3415-25. PubMed ID: 9310336
[TBL] [Abstract][Full Text] [Related]
12. Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines.
Maciewicz RA; Wardale RJ; Etherington DJ; Paraskeva C
Int J Cancer; 1989 Mar; 43(3):478-86. PubMed ID: 2647640
[TBL] [Abstract][Full Text] [Related]
13. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
[TBL] [Abstract][Full Text] [Related]
14. Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines.
Zajc I; Sever N; Bervar A; Lah TT
Cancer Lett; 2002 Dec; 187(1-2):185-90. PubMed ID: 12359367
[TBL] [Abstract][Full Text] [Related]
15. Cystatins and cathepsins in breast carcinoma.
Lah TT; Kokalj-Kunovar M; Drobnic-Kosorok M; Babnik J; Golouh R; Vrhovec I; Turk V
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):595-604. PubMed ID: 1515089
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Colella R; Denhardt DT; Wilson SM
Mol Carcinog; 1992; 5(3):238-45. PubMed ID: 1586450
[TBL] [Abstract][Full Text] [Related]
17. Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.
Podgorski I; Linebaugh BE; Sameni M; Jedeszko C; Bhagat S; Cher ML; Sloane BF
Neoplasia; 2005 Mar; 7(3):207-23. PubMed ID: 15799821
[TBL] [Abstract][Full Text] [Related]
18. Effect of cysteine proteinase inhibitors on murine B16 melanoma cell invasion in vitro.
Sever N; Filipic M; Brzin J; Lah TT
Biol Chem; 2002 May; 383(5):839-42. PubMed ID: 12108549
[TBL] [Abstract][Full Text] [Related]
19. Changes of lysosomal proteinase activities and their expression in rat cultured keratinocytes during differentiation.
Tanabe H; Kumagai N; Tsukahara T; Ishiura S; Kominami E; Nishina H; Sugita H
Biochim Biophys Acta; 1991 Sep; 1094(3):281-7. PubMed ID: 1911879
[TBL] [Abstract][Full Text] [Related]
20. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy.
Rinne R; Saukko P; Järvinen M; Lehesjoki AE
Ann Med; 2002; 34(5):380-5. PubMed ID: 12452481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]